Biktarvy

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 61958-2505
  • Package NDC 61958-2505-1
  • Application number NDA210251
  • SPL ID 261dcc2a-c849-46b1-abf6-4981ed2c60bc
  • SPL set ID 664cb8f0-1f65-441b-b0d9-ba3d798be309
  • UNII 4L5MP1Y7W7
  • UNII FWF6Q91TZO
  • UNII G70B4ETF4S
  • RxCUI 1999667
  • RxCUI 1999673
  • RxCUI 2584354
  • RxCUI 2584356

What the source publishes

Labeler
Gilead Sciences, Inc.
Active ingredients
bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:61958-2505_261dcc2a-c849-46b1-abf6-4981ed2c60bc
{
  "name": "Biktarvy",
  "splId": "261dcc2a-c849-46b1-abf6-4981ed2c60bc",
  "labels": [
    {
      "setId": "664cb8f0-1f65-441b-b0d9-ba3d798be309",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=664cb8f0-1f65-441b-b0d9-ba3d798be309",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=664cb8f0-1f65-441b-b0d9-ba3d798be309"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Gilead Sciences, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET in 1 BOTTLE, PLASTIC (61958-2505-1)",
      "package_ndc": "61958-2505-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20211007"
    }
  ],
  "productId": "61958-2505_261dcc2a-c849-46b1-abf6-4981ed2c60bc",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "61958-2505",
  "deaSchedule": null,
  "genericName": "bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "BICTEGRAVIR SODIUM",
      "strength": "30 mg/1"
    },
    {
      "name": "EMTRICITABINE",
      "strength": "120 mg/1"
    },
    {
      "name": "TENOFOVIR ALAFENAMIDE FUMARATE",
      "strength": "15 mg/1"
    }
  ],
  "applicationNumber": "NDA210251",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20211007",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175462",
      "M0015066",
      "N0000009947"
    ],
    "unii": [
      "4L5MP1Y7W7",
      "FWF6Q91TZO",
      "G70B4ETF4S"
    ],
    "rxcui": [
      "1999667",
      "1999673",
      "2584354",
      "2584356"
    ],
    "spl_set_id": [
      "664cb8f0-1f65-441b-b0d9-ba3d798be309"
    ],
    "pharm_class_cs": [
      "Nucleosides [CS]"
    ],
    "pharm_class_epc": [
      "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Gilead Sciences, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:61958-2505_261dcc2a-c849-46b1-abf6-4981ed2c60bc"